Abstract
The development of infantile and childhood bullous pemphigoid following vaccination was already documented in several cases. This post-vaccination autoimmune phenomenon is part of the autoimmune/inflammatory syndrome induced by adjuvants (ASIA). A 4 months old female patient, presented with bullous skin rash, two months following her second inoculation with the hepatitis B vaccine (HBVv). In addition, during the appearance of the rash she received the second dose of hexavalent INFANRIX™-IPV/Hib vaccine (GSK), which was followed by irritability and fever. According to the clinical picture, biopsy result, direct immune fluorescent (DIF) and indirect immune fluorescent (IIF), a diagnosis of infantile bullous pemphigoid (BP) was determined. The patient was resistant to most conventional therapies. We report a case of an infantile BP, which appeared following immunization with HBVv. This case depicts a temporal association between the appearance of autoimmune diseases and vaccines. The appearance of bullous dermatoses following vaccinations was reported in 14 case reports. The physicians should be aware of the option of such link and further inquiry is warranted.
Highlights
Bullous Pemphigoid (BP) is an autoimmune blistering disease of the skin, which typically appears in the elderly with a peak incidence in the seventh decade [1]
We report a case of an infantile BP, which appeared following immunization with HBVv
We describe a 4-month-old female child that following her second inoculation with hepatitis B vaccine (HBVv), developed bullous eruption compatible with BP which was refractory to most systemic therapies
Summary
Bullous Pemphigoid (BP) is an autoimmune blistering disease of the skin, which typically appears in the elderly with a peak incidence in the seventh decade [1]. We report a case of an infantile BP, which appeared following immunization with HBVv. This case depicts a temporal association between the appearance of autoimmune diseases and vaccines.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have